Viyash Scientific (512529) Q4 97/98 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 97/98 earnings summary
29 Oct, 2026Executive summary
FY1997-98 reported profit before tax of Rs 53,149 and profit after tax of Rs 36,882; earnings were retained for future operations.
Year-end assets totaled Rs 2,790,182, funded by Rs 2,400,000 share capital and Rs 390,182 reserves and surplus.
Financial highlights
Other income was Rs 89,475 versus Rs 36,481 in FY1996-97; administrative and other expenses were Rs 36,327 versus Rs 34,686.
Profit before tax was Rs 53,149; provision for tax was Rs 16,267 and reported profit after tax was Rs 36,882.
Reserves and surplus rose to Rs 390,182 from Rs 353,300.
Outlook and guidance
Earnings were retained to support future operations; no dividend was recommended.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Viyash Scientific
- Investment-sale gains lifted FY99 PAT to ₹1.653m; earnings were retained and no dividend recommended.512529
Q4 98/99 - FY02 loss narrowed, but Rs 55.57m in advances remained subject to confirmation.512529Q4 01/02
- FY03 loss widened as Rs 54.50m in loans and advances dominated the balance sheet.512529Q4 02/03
- ₹295.51 lakh FY04 net profit; growth guidance exceeded 50% post-amalgamation.512529Q4 03/04
- FY05 profit rose as capacity expansion and new markets became central priorities.512529Q4 04/05
- FY06 growth and new capacity supported expansion, while rising input costs remained a key risk.512529Q4 05/06
- Sales climbed 23%; adjusted PAT rose 32% as R&D and veterinary APIs set the growth agenda.512529Q4 06/07
- Transchem expanded the business as currency pressure and higher costs squeezed profit.512529Q4 07/08
- Standalone profit grew, but consolidation swung to a ₹1,466 lakh net loss.512529Q4 08/09